In case of a BC diagnosis under the age of 35, annual rates of contralateral BC are almost twice as high among women with LFS compared to female carriers of a P/LP variant in BRCA1 or BRCA2 (7.0% vs. 3.6% or 2.6%).17 Here, BRCA2 is linked to breast cancer.